Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 6 of 600 for:    Anti-Infective Agents AND susceptibility

Bacterial and Antimicrobial Susceptibility Profile and the Prevalence of Different Sites of Infection(BASPP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03333863
Recruitment Status : Active, not recruiting
First Posted : November 7, 2017
Last Update Posted : November 7, 2017
Sponsor:
Information provided by (Responsible Party):
Hongyu Zhao, Shengjing Hospital

Brief Summary:
Positive results of bacterial culture are analyzed comprehensively in Shengjing Hospital of China Medical University in recent 3 years(between 2015- 2017)

Condition or disease Intervention/treatment
Infectious Diseases in Pneumonia,Nephropyelitis,Angiocholitis or Others Positive Bacterial Cultures Results of the Medical Records Other: descriptive study which reviewed the data of patients hospitalized with positive bacterial cultures

Layout table for study information
Study Type : Observational
Estimated Enrollment : 1000 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Bacterial and Antimicrobial Susceptibility Profile and the Prevalence of Different Sites of Infection in Shengjing Hospital of China Medical University: a Retrospective, Descriptive Study
Actual Study Start Date : October 25, 2017
Estimated Primary Completion Date : June 30, 2018
Estimated Study Completion Date : October 31, 2018

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: descriptive study which reviewed the data of patients hospitalized with positive bacterial cultures
    A retrospective, descriptive study was conducted at shengjing hospital of China Medical University between 2015- 2017. Data regarding bacterial culture isolates, antimicrobial susceptibility spectrum, and the general data of patients with fever or suspicion of sepsis were collected.


Primary Outcome Measures :
  1. bacterial and antimicrobial susceptibility profile [ Time Frame: From January 2015 to December 2017 ]
    Primary outcome was recording the results of bacterial and antimicrobial susceptibility profile of pneumonia, nephropyelitis, or angiocholitis, measured with statistical methods.


Secondary Outcome Measures :
  1. patient's critical condition [ Time Frame: From January 2015 to December 2017 ]
    Secondary outcome was evaluating the patient's critical condition, measured with APACHE (acute physiology and chronic health evaluation) II score.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients hospitalized with positive bacterial cultures results in blood, urine, sputum, and secretion, are enrolled at shengjing hospital of China Medical University from January 2015 to December 2017.
Criteria

Inclusion Criteria:

  • Clinical diagnosis of pneumonia, nephropyelitis, angiocholitis or other infectious diseases
  • Positive results of bacterial cultures in blood, urine, sputum, and secretion
  • The medical records of shengjing hospital of China Medical University from January 2015 to December 2017

Exclusion Criteria:

  • Negative results of bacterial cultures in blood, urine, sputum, and secretion

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03333863


Locations
Layout table for location information
China, Liaoning
Shengjing hospital of China Medical University
Shenyang, Liaoning, China, 110004
Sponsors and Collaborators
Shengjing Hospital
Investigators
Layout table for investigator information
Principal Investigator: Hongyu Zhao, doctor Shengjing Hospital

Publications:
Layout table for additonal information
Responsible Party: Hongyu Zhao, Clinical Professor, Shengjing Hospital
ClinicalTrials.gov Identifier: NCT03333863     History of Changes
Other Study ID Numbers: BASPP
First Posted: November 7, 2017    Key Record Dates
Last Update Posted: November 7, 2017
Last Verified: November 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Disease Susceptibility
Anti-Infective Agents
Anti-Bacterial Agents
Pneumonia
Communicable Diseases
Infection
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Disease Attributes
Pathologic Processes